We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.89B
AUM Growth
+$125M
Cap. Flow
-$226M
Cap. Flow %
-5.82%
Top 10 Hldgs %
15.92%
Holding
230
New
17
Increased
95
Reduced
68
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Consumer Discretionary 15.66%
3 Healthcare 15.51%
4 Industrials 11.08%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MWIV
226
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
-31,550
Closed -$4.71M
FLOW
227
DELISTED
FLOW INTL CORP
FLOW
-308,000
Closed -$1.23M
ELN
228
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
-1,113,373
Closed -$17.3M
FIRE
229
DELISTED
SOURCEFIRE INC COM STK
FIRE
-98,300
Closed -$7.46M
ONXX
230
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
-300,800
Closed -$37.5M

Similar funds

Granahan Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Granahan Investment Management held 230 positions worth $3.89B, up 3.3% from $3.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $226M in Q4 2013, closing 21 positions and reducing 68 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Granahan Investment Management opened a new position in Deckers Outdoor worth $33.8M.

  • Granahan Investment Management's largest Q4 2013 buy was Deckers Outdoor: 2,399,400 shares worth $33.8M.
  • Granahan Investment Management added most to A T M I INC in Q4 2013, an estimated $32.5M increase.
  • Granahan Investment Management's biggest Q4 2013 reduction was Sotheby's, cutting an estimated $27.7M.
  • Granahan Investment Management fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $40.1M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.89B portfolio in Q4 2013.
  • Granahan Investment Management opened 17 new positions and closed 21 in Q4 2013.
  • Granahan Investment Management's portfolio value rose 3.3% quarter-over-quarter to $3.89B.

Based on Granahan Investment Management's 13F filing for Q4 2013, filed 30 Jan 2014.